
Onn Hafiz: Johor not asking for handouts, just a fair return
The proposed revenue share is intended to fast-track essential infrastructure upgrades, improve healthcare delivery, enhance flood mitigation efforts and expand social welfare services across the state.
Johor Menteri Besar Datuk Onn Hafiz Ghazi said the proposal was rooted in economic reality and state interest, not politics.
"Johor has consistently proven itself to be one of the top contributors to Malaysia's economy.
"We are not asking for handouts… we are asking for a fair return to continue driving national progress," he said in a post uploaded on his Facebook today.
Onn Hafiz added that the request reflected Johor's position as a strategic economic engine, not merely a statistical contributor to federal coffers.
In the first quarter of 2025, Johor recorded RM30.1 billion in approved investments, the highest in the country.
In 2024, Johor also led in GDP growth with 6.4 per cent, exceeding the national average of 5.1 per cent.
In agriculture, the state posted RM27.2 billion in sales, the highest nationwide.
"If just a quarter of what we contribute can be reinvested into Johor, the returns will benefit not only our people but the entire country," he added.
Onn Hafiz said the proposal was made in the spirit of cooperation with Putrajaya, not confrontation, and aligned with a broader vision of fiscal equity and shared prosperity.
Yesterday, Tunku Ismail urged the federal government to return 25 per cent of Johor's income tax revenue, citing the delayed opening of Pasir Gudang Hospital as a clear sign of underfunding.
Tunku Ismail expressed disappointment over the postponement of Pasir Gudang Hospital's opening, which was initially scheduled to begin phased operations next month but has now been delayed to January next year.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Straits Times
7 hours ago
- New Straits Times
Cambodia PM agrees to ceasefire proposed by Anwar
PHNOM PENH: Cambodian Prime Minister Hun Manet has agreed to the ceasefire proposal with Thailand suggested by Malaysian Prime Minister Datuk Seri Anwar Ibrahim. In a Facebook post today, Manet said he agreed to the ceasefire because Cambodia did not initiate the fighting. "The key to resolving the current armed conflict between Thailand and Cambodia is the genuine willingness of the Thai side to accept a ceasefire, which is the first step towards finding further solutions between the two countries," Manet said in his posting. Manet clarified that there was unclear reporting by various international media regarding the proposed ceasefire talks initiated by Anwar, the current Asean chair. Manet said he only agreed to the ceasefire after hearing from Anwar that Thailand's acting Prime Minister, Phumtham Wechayachai, agreed to peace talks. But regrettably, the Thai side changed their position on the issue, he said in his posting. "However, it is regrettable that just over an hour later, the Thai side informed that they had reversed their position from agreeing to the ceasefire," said Manet. Anwar said he spoke to both prime ministers on resolving the ongoing conflict on Thursday. The border conflict between Cambodia and Thailand escalated after soldiers from both sides engaged in a clash on Thursday morning along the Oddar Meanchey and Preah Vihear areas. The two neighbours have been quarrelling over an 817-km undemarcated border for decades, which has harmed diplomatic ties. - Bernama


Malaysian Reserve
8 hours ago
- Malaysian Reserve
Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
INDIANAPOLIS, July 25, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc. (Nasdaq: VERV). Verve is a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease. 'This acquisition unlocks the opportunity to potentially transform the treatment paradigm for millions of patients worldwide by delivering lifelong cardiovascular risk reduction with a one-and-done treatment,' said Ruth Gimeno, Lilly group vice president, Diabetes and Metabolic Research and Development. 'We are excited to welcome Verve colleagues to Lilly and work together to develop innovative genetic medicines for cardiometabolic disease.' About LillyLilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit and or follow us on Facebook, Instagram, and LinkedIn. F-LLY Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements regarding Lilly's acquisition of Verve, regarding prospective benefits of the acquisition and Verve's gene editing programs for cardiovascular disease, regarding Verve's product candidates and ongoing clinical and preclinical development, and regarding Lilly's development of programs for cardiovascular disease and advancement of cardiometabolic health medicines. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements reflect current beliefs and expectations; however, these statements involve inherent risks and uncertainties, including with respect to drug research, development and commercialization, Lilly's evaluation of the accounting treatment of the acquisition and its potential impact on its financial results and financial guidance, regulatory changes and developments, the impact of global macroeconomic conditions, including trade and other global disputes and interruptions, including related to tariffs, trade protection measures, and similar restrictions, risks that the acquisition disrupts current plans and operations or adversely affect employee retention, and any legal proceedings that have been or may be instituted related to the acquisition. Actual results could differ materially due to various factors, risks and uncertainties. Among other things, there can be no guarantee that Lilly will realize the expected benefits of the acquisition, that product candidates will be approved on anticipated timelines or at all, that any products, if approved, will be commercially successful, that all or any of the contingent consideration will become payable on the terms described herein or at all, that Lilly's financial results will be consistent with its expected 2025 guidance or that Lilly can reliably predict the impact of the acquisition on its financial results or financial guidance. For further discussion of these and other risks and uncertainties, see Lilly's most recent Form 10-K and Form 10-Q filings with the U.S. Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this press release. Refer to: Ashley Hennessey; gentry_ashley_jo@ 317-416-4363 (Media) Michael Czapar; czapar_michael_c@ 317-617-0983 (Investors)

Barnama
9 hours ago
- Barnama
Cambodia PM Agrees To Ceasefire Proposed By Anwar
By Vijian Paramasivam PHNOM PENH, July 25 (Bernama) -- Cambodian Prime Minister Hun Manet has agreed to the ceasefire proposal with Thailand suggested by Malaysian Prime Minister Datuk Seri Anwar Ibrahim. In a Facebook post today, Manet said he agreed to the ceasefire because Cambodia did not initiate the fighting. bootstrap slideshow 'The key to resolving the current armed conflict between Thailand and Cambodia is the genuine willingness of the Thai side to accept a ceasefire, which is the first step towards finding further solutions between the two countries,' Manet said in his posting. Manet clarified that there was unclear reporting by various international media regarding the proposed ceasefire talks initiated by Anwar, the current ASEAN chair. Manet said he only agreed to the ceasefire after hearing from Anwar that Thailand's acting Prime Minister, Phumtham Wechayachai, agreed to peace talks. But regrettably, the Thai side changed their position on the issue, he said in his posting. 'However, it is regrettable that just over an hour later, the Thai side informed that they had reversed their position from agreeing to the ceasefire,' said Manet. Anwar said he spoke to both prime ministers on resolving the ongoing conflict on Thursday.